Inder Sehgal, DVM, PhD, CPhT

Professor of Foundational Sciences, Pharmacology

Dr. Sehgal’s research spans both laboratory bench science and educational pedagogy. He spent a decade developing mouse tumor models of prostate, breast and colon cancers, initially to advance his own work and later in collaboration with chemists, molecular biologists, virologists and toxicologists. Through these partnerships, he contributed to the development of a third-generation oncolytic herpes-simplex virus for prostate and breast cancer immunotherapy. He also collaborated on the design and synthesis of phthalocyanine–monoclonal antibody and EGF-receptor ligand conjugates for early colon cancer detection. These projects were supported by NIH funding, including an R01 grant for the phthalocyanine imaging work. He also collaborated to establish a rat model of tinnitus that was supported by a Department of Defense grant.

Beyond academia, Dr. Sehgal has applied his expertise in industry, serving as a formulator and cosmetic chemist for a personal care start-up, where he developed oil-in-water and water-in-oil emulsion face creams, shampoos, conditioners, body lotions, mosquito repellents, hand sanitizers, surface disinfectants and over-the-counter compounds.

In addition to bench research, Dr. Sehgal has pursued a long-standing interest in interprofessional education (IPE). Recognizing IPE as a critical element in accreditation standards across health professions programs—including allopathic, osteopathic, dental, veterinary and pharmacy schools—he actively advances interprofessional collaboration in medical education. As a pharmacologist and educator, he continues to explore opportunities to support students across multiple disciplines.